Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, May 1, 2015
Question of the Day May 1, 2015 If compounders were to challenge the DQSA in federal court would legislative intent even be looked at based on language in the statute that was passed? Is a court challenge in the near future? Why hasn't it already been done in light of the 483s issued to compounding pharmacies? Is it because the argument is meritless? Why or why not? Is that the only way to resolve the issue since Congress has not introduced an amend to the DQSA in the manner that compounders and groups that represent them want it to be interpreted? Should Congress reexamine the authority it granted to the FDA? Give it more authority over compounding pharmacies? Less? Why or why not?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment